Form4insider filings, from the source

SEC Form 4 · accession 0001055726-18-000011

INOVIO PHARMACEUTICALS, INC. · INO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Mark Bagarazzi
Officer — Chief Medical Officer
Period of report
Mar 9, 2018
Accepted (ET)
Mar 13, 2018 · 6:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001055726

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Mar 9, 2018M25,000—A73,628D
Common StockMar 9, 2018F6,896$4.51D66,732D
Common StockF3Mar 10, 2018M20,434—A87,166D
Common StockMar 10, 2018F5,653$4.51D81,513D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitF1—Mar 9, 2018M25,000D——Common Stock25,00025,000D
Restricted Stock UnitF3—Mar 10, 2018M20,434D——Common Stock20,43440,866D

Explanation of responses